药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Diphenoxylate
Metoprine
The therapeutic efficacy of Metoprine can be decreased when used in combination with 5-methyltetrahydrofolic acid.
Diphenoxylate
Piritrexim
The therapeutic efficacy of Piritrexim can be decreased when used in combination with 5-methyltetrahydrofolic acid.
Diphenoxylate
Proguanil
The therapeutic efficacy of Proguanil can be decreased when used in combination with 5-methyltetrahydrofolic acid.
Diphenoxylate
Glucarpidase
The serum concentration of the active metabolites of 5-methyltetrahydrofolic acid can be reduced when 5-methyltetrahydrofolic acid is used in combination with Glucarpidase resulting in a loss in efficacy.
Diphenoxylate
Fosphenytoin
The serum concentration of Fosphenytoin can be decreased when it is combined with 5-methyltetrahydrofolic acid.
Deslanoside
Capmatinib
The serum concentration of Camptothecin can be increased when it is combined with Capmatinib.
Deslanoside
Tafamidis
The serum concentration of Camptothecin can be increased when it is combined with Tafamidis.
Deslanoside
Darolutamide
The serum concentration of Camptothecin can be increased when it is combined with Darolutamide.
Deslanoside
Lasmiditan
The serum concentration of Camptothecin can be increased when it is combined with Lasmiditan.
Deslanoside
Apalutamide
Apalutamide may increase the excretion rate of Camptothecin which could result in a lower serum level and potentially a reduction in efficacy.
Deslanoside
Pralsetinib
Pralsetinib may decrease the excretion rate of Camptothecin which could result in a higher serum level.
Deslanoside
Fostemsavir
Fostemsavir may decrease the excretion rate of Camptothecin which could result in a higher serum level.
Deslanoside
Ripretinib
Ripretinib may decrease the excretion rate of Camptothecin which could result in a higher serum level.
Deslanoside
Glecaprevir
Glecaprevir may decrease the excretion rate of Camptothecin which could result in a higher serum level.
Deslanoside
Pibrentasvir
Pibrentasvir may decrease the excretion rate of Camptothecin which could result in a higher serum level.
Deslanoside
Enasidenib
Enasidenib may decrease the excretion rate of Camptothecin which could result in a higher serum level.
Deslanoside
Rucaparib
Rucaparib may decrease the excretion rate of Camptothecin which could result in a higher serum level.
Deslanoside
Letermovir
Letermovir may decrease the excretion rate of Camptothecin which could result in a higher serum level.
Deslanoside
Voxilaprevir
Voxilaprevir may decrease the excretion rate of Camptothecin which could result in a higher serum level.
Deslanoside
Abemaciclib
Abemaciclib may decrease the excretion rate of Camptothecin which could result in a higher serum level.